The cardiovascular health activities are in response to the growing burden of these diseases due to the social, demographic, epidemiologic and health care transitions that have led to cardiovascular diseases being the number one cause of death in the country.
The activities are dedicated to:
| Sl No. | Title | Authors | Journal Name | Publication Year |
|---|---|---|---|---|
| 46 | Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study | O'Donnell M, Mente A, Rangarajan S, McQueen MJ, O'Leary N, Yin L, Liu X, Swaminathan S, Khatib R, Rosengren A, Ferguson J, Smyth A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Ismail N, Yusoff K, Dans A, Iqbal R, Szuba A, Mohammadifard N, Oguz A, Yusufali AH, Alhabib KF, Kruger IM, Yusuf R, Chifamba J, Yeates K, Dagenais G, Wielgosz A, Lear SA, Teo K, Yusuf S; PURE Investigators | BMJ | 2019 |
| 47 | Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study | Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, Avezum A, Bengtsson Boström K, Chifamba J, Gulec S, Gupta R, Igumbor EU, Iqbal R, Ismail N, Joseph P, Kaur M, Khatib R, Kruger IM, Lamelas P, Lanas F, Lear SA, Li W, Wang C, Quiang D, Wang Y, Lopez-Jaramillo P, Mohammadifard N, Mohan V, Mony PK, Poirier P, Srilatha S, Szuba A, Teo K, Wielgosz A, Yeates KE, Yusoff K, Yusuf R, Yusufali AH, Attaei MW, McKee M, Yusuf S | Lancet Glob Health | 2019 |
| 48 | Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study | DuongM, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, Rahman O, Yusoff K, du Plessis JL, Igumbor EU, Chifamba J, Li W, Lu Y, Zhi F, Yan R, Iqbal R, Ismail N, Zatonska K, Karsidag K, Rosengren A, Bahonar A, Yusufali A, Lamelas PM, Avezum A, Lopez-Jaramillo P, Lanas F, O'Byrne PM, Yusuf S; PURE investigators. | Lancet Glob Health | 2019 |
| 49 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial | Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. | Lancet | 2019 |
| 50 | Association between complications and death within 30 days after noncardiac surgery | Spence J, LeManach Y, Chan MTV, Wang CY, Sigamani A, Xavier D, Pearse R, Alonso-Coello P, Garutti I, Srinathan SK, Duceppe E, Walsh M, Borges FK, Malaga G, Abraham V, Faruqui A, Berwanger O, Biccard BM, Villar JC, Sessler DI, Kurz A, Chow CK, Polanczyk CA, Szczeklik W, Ackland G, Garg AX, Jacka M, Guyatt GH, Sapsford RJ, Williams C, Cortes OL, Coriat P, Patel A, Tiboni M, Belley-Côté EP, Yang S, Heels-Ansdell D, McGillion M, Schünemann HJ, Parlow S, Patel M, Pettit S, Yusuf S, Devereaux PJ; on behalf of the VISION Investigators | CMAJ | 2019 |
| 51 | Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial | Joshi R, Agrawal T, Fathima F, Usha T, Thomas T, Misquith D, Kalantri S, Chidambaram N, Raj T, Singamani A, Hegde S, Xavier D, Devereaux PJ, Pais P, Gupta R, Yusuf S | Am Heart J | 2019 |
| 52 | Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study | Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O'Donnell M, McKee M, Dagenais G | Lancet | 2019 |
| 53 | Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial | Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators. | Circulation | 2019 |
| 54 | Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study | Annika Rosengren 1, Andrew Smyth 2, Sumathy Rangarajan 3, Chinthanie Ramasundarahettige 3, Shrikant I Bangdiwala 3, Khalid F AlHabib 4, Alvaro Avezum 5, Kristina Bengtsson Boström 6, Jephat Chifamba 7, Sadi Gulec 8, Rajeev Gupta 9, Ehi U Igumbor 10, Romaina Iqbal 11, Norhassim Ismail 12, Philip Joseph 3, Manmeet Kaur 13, Rasha Khatib 14, Iolanthé M Kruger 15, Pablo Lamelas 3, Fernando Lanas 16, Scott A Lear 17, Wei Li 18, Chuangshi Wang 18, Deren Quiang 19, Yang Wang 18, Patricio Lopez-Jaramillo 20, Noushin Mohammadifard 21, Viswanathan Mohan 22, Prem K Mony 23, Paul Poirier 24, Sarojiniamma Srilatha 25, Andrzej Szuba 26, Koon Teo 3, Andreas Wielgosz 27, Karen E Yeates 28, Khalid Yusoff 29, Rita Yusuf 30, Afzalhusein H Yusufali 31, Marjan W Attaei 3, Martin McKee 32, Salim Yusuf 3 | Lancet Glob Health | 2019 |
| 55 | The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016 | Prabhakaran D, Jeemon P, Sharma M, Roth GA, Johnson C, Harikrishnan S, Gupta R, Pandian JD, Naik N, Roy A, Dhaliwal RS, Xavier D, et al; India State-Level Disease Burden Initiative CVD Collaborators | Lancet Glob Health | 2018 |
| 56 | Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study | Mahshid Dehghan, PhD Andrew Mente, PhD Sumathy Rangarajan, MSc Patrick Sheridan, MSc Prof Viswanathan Mohan, MD Romaina Iqbal, PhD Prof Rajeev Gupta, MD Prof Scott Lear, PhD Prof Edelweiss Wentzel-Viljoen, PhD Prof Alvaro Avezum, MD Prof Patricio Lopez-Jaramillo, MD Prem Mony, MD Ravi Prasad Varma, MD Prof Rajesh Kumar, MD Jephat Chifamba, DPhil Khalid F Alhabib, MBBS Noushin Mohammadifard, PhD Prof Aytekin Oguz, MD Prof Fernando Lanas, MD Prof Dorota Rozanska, PhD Prof Kristina Bengtsson Bostrom, MD Prof Khalid Yusoff, MBBS Lungiswa P Tsolkile, MPH Prof Antonio Dans, MD Prof AfzalHussein Yusufali, MD Andres Orlandini, MD Prof Paul Poirier, MD Rasha Khatib, PhD Bo Hu, PhD Prof Li Wei, PhD Lu Yin, PhD Ai Deeraili, MD Karen Yeates, MD Prof Rita Yusuf, DPhil Prof Noorhassim Ismail, MD Prof Dariush Mozaffarian, MD Prof Koon Teo, MBBCh Prof Sonia S Anand, MD Prof Salim Yusuf, PhD on behalf of theProspective Urban Rural Epidemiology (PURE) study investigators† | Lancet | 2018 |
| 57 | Low quality cardiovascular care is important coronary risk factor in India | Gupta R, Khedar RS, Gaur K, Xavier D | Indian Heart Journal | 2018 |
| 58 | Effect of intensive lifestyle modification & metformin on cardiovascular risk in prediabetes: A pilot randomized control trial | Kulkarni S, Xavier D, George B, Umesh S, Fathima S, Bantwal G | Indian J Med Res | 2018 |
| 59 | Treadmill stress tests should not be part of "routine health check package" | Pais P | Indian Heart Journal | 2018 |
| 60 | Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide | Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riddle MC, Rydén L, Xavier D, Atisso CM, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona-Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw J, Sheu WH, Temelkova-Kurktschiev T; REWIND Trial Investigators. | Diabetes Obes Metab | 2018 |